Turbine Discs Broaching Machines
Turbine disc broaching machine is a machine tool specially used for broaching turbine discs in ai ... Read More
Cell freezing medium is a complete cell freezing media for mammalian cell cultures.
Most classic formulations of cell freezing media containing dimethyl sulfoxide (DMSO) as the active freezing agent. However, since it is known that DMSO is a mutagen and carcinogen, DMSO-free formulations are becoming popular for stem cell applications. This is an especially critical consideration for cells being used in translational research or clinical applications. Moreover, media formulations that are manufactured under GMP compliance and have drug-master files registered with government regulatory agencies provide added value for regenerative medicine use.
Market Analysis and Insights: Global and United States Cell Freezing Media for Cell Therapy Market
This report focuses on global and United States Cell Freezing Media for Cell Therapy market, also covers the segmentation data of other regions in regional level and county level.
Due to the COVID-19 pandemic, the global Cell Freezing Media for Cell Therapy market size is estimated to be worth US$ 91 million in 2022 and is forecast to a readjusted size of US$ 198.8 million by 2028 with a CAGR of 13.8% during the forecast period 2022-2028. Fully considering the economic change by this health crisis, by Type, With FBS accounting for % of the Cell Freezing Media for Cell Therapy global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While by Application, Human Embryonic Stem Cells was the leading segment, accounting for over percent market share in 2021, and altered to an % CAGR throughout this forecast period.
Market competition is intense. BioLife Solutions, Thermo Fisher Scientific, Merck, Cytiva, Zenoaq, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers. The Top 5 manufacturers occupied 84.84% of global market share in 2021.
Global Cell Freezing Media for Cell Therapy Scope and Market Size
Cell Freezing Media for Cell Therapy market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Cell Freezing Media for Cell Therapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
For United States market, this report focuses on the Cell Freezing Media for Cell Therapy market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.
Segment by Type
With FBS
Without FBS
Segment by Application
Human Embryonic Stem Cells
CAR-T Cell Therapy
Neural Stem Cell Therapy
Mesenchymal Stem Cell Therapy
Hematopoietic Stem Cell Transplantation
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
BioLife Solutions
Thermo Fisher Scientific
Merck
Cytiva
Zenoaq
WAK-Chemie Medical
Sartorius
Akron Biotechnology
Sansheng Bio
Youkang Bio
Turbine disc broaching machine is a machine tool specially used for broaching turbine discs in ai ... Read More
A Electric Coolant Pump is a type of pump used to recirculate a coolant, generally a liquid, that ... Read More
Robotic total station, also known as measuring robot, is the measurement platform with automatic ... Read More
Because completed wafers are thinner compared to their areas and are susceptible to contamination ... Read More